Yep, just don't see a timeline, which in these kinda stocks is a good fwd looking target for them and investors alike. Only -
"The Company remains well funded to reach its key milestones and will focus its capital on its core R&D
program including clinical evaluation, product manufacturing and commercialisation."
Basically confirming no need for new capital this year.
Ann: December 2019 Quarterly Activities and Cashflow Reports, page-12
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AC8 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| AC8 (ASX) Chart |
Day chart unavailable